(Q73111092)

English

Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year

scientific article published on 01 February 1997

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Effects of low-dose pravastatin sodium on plasma cholesterol levels and aortic atherosclerosis of heterozygous WHHL rabbits fed a low cholesterol (0.03%) enriched diet for one year (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

aortic atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M Harsch

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

J H Braesen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Niendorf

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 February 1997

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

139-147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Cellular pathology of progressive atherosclerosis in the WHHL rabbit. An animal model of familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Concentration and composition of lipoproteins in blood plasma of the WHHL rabbit. An animal model of human familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Defective lipoprotein receptors and atherosclerosis. Lessons from an animal counterpart of familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Induction of mRNA for low-density lipoprotein receptors in heterozygous Watanabe heritable hyperlipidemic rabbits treated with CS-514 (Pravastatin) and cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Effects of pravastatin on cholesterol metabolism in Watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factors. The Pravastatin Multinational Study Group for Cardiac Risk Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

The rapid reduction in cardiac events with lipid-lowering therapy: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Pravastatin, lipids, and major coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Probucol inhibits not only the progression of atherosclerotic disease, but causes a different composition of atherosclerotic lesions in WHHL-rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Effect of lovastatin on cholesterol absorption in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Sterol balance and cholesterol absorption in inbred strains of rabbits hypo- or hyperresponsive to dietary cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Simvastatin but not pravastatin inhibits the proliferation of rat aorta myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Reduction of serum cholesterol levels alters lesional composition of atherosclerotic plaques. Effect of pravastatin sodium on atherosclerosis in mature WHHL rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

Cholesterol lowering as a treatment for established coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

A Heritable Hyperlipemic Rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2896%2905986-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9150(96)05986-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9050770%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73111092&oldid=2221529350"